Efland, NC, United States of America

Frank J Schoenen

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Inc.. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank J Schoenen. Retrieved from https://idiyas.com/inventor/frank-j-schoenen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frank J Schoenen: Innovator in Aminobutanoic Acid Compounds

Introduction

Frank J Schoenen is a notable inventor based in Efland, North Carolina. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on aminobutanoic acid compounds.

Latest Patents

Schoenen holds a patent for aminobutanoic acid compounds that possess metalloprotease inhibiting properties. His patent details aminobutanoic acids of a specific formula, where various substituents can be applied. This invention includes novel intermediates and a pharmaceutical composition aimed at treating inflammatory diseases, demyelinating diseases, and tumor metastasis. Additionally, it outlines methods for such treatments and processes for preparing the compounds of the specified formula.

Career Highlights

Throughout his career, Frank J Schoenen has been associated with Glaxo Inc., where he has furthered his research and development efforts. His work has been instrumental in advancing therapeutic options for various medical conditions.

Collaborations

Schoenen has collaborated with notable colleagues, including Andrew B McElroy and Peter J Brown, contributing to a dynamic research environment that fosters innovation.

Conclusion

Frank J Schoenen's contributions to the field of medicinal chemistry through his patent on aminobutanoic acid compounds highlight his role as an influential inventor. His work continues to impact the development of treatments for critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…